Group introduced two different types of medications to treat diabetes. These are oral hypoglycemic drugs. Pharmacodynamics of each medication were clearly discussed. This includes groupings Sulfonylureas and Megitinides, as well as medications like chlorpropamide, glyburide, and glimpiride (Gaddie 2016).
Group clearly stated what drugs were not to be taken together, food interactions (if any), and other indicators such as noncompliance. Sulfonylureas with longer half-lives, for example, should be taken once daily and administered with food and those meals skipped should have a skipped dose (Gaddie 2016).
Dosing amounts, including average, minimum, and maximum were discussed. Routines and dosage are different for different ages, weights, and people with different health issues. These were outlined in the presentation (Gaddie 2016).
Labs should be ordered prior to beginning treatment and monitoring through evidence-based practices should occur every three months. The group also touched on patient teaching (Gaddie 2016).
As mentioned previously, the half-life of applicable medications was discussed. Differences between first and second generation drugs were outlined, including absorption. These drugs highly bond to proteins and are metabolized by the liver (Gaddie 2016).
Gaddie, A., Kinsel, H. & Miller, J. (2016)."Sulfonylureas & Meglitinides". Presentation.